You are here:Home1/Dr. Christopher-Paul Milne – Faculty
Dr. Christopher-Paul Milne
Dr. Christopher-Paul Milne joined the Center for the Study of Drug Development at the Tufts University School of Medicine (Tufts CSDD) in Boston over 20 years ago as a Senior Research Fellow and has published over 100 book chapters, white papers, and journal articles. His research interests include: disease, demographic, and market access factors in the emerging markets; incentive programs for pediatric studies, orphan products, and medical countermeasures (MCMs); and, tracking the progress of new regulatory and research initiatives such as facilitated regulatory pathways (FRPs), regulatory science, as well as regenerative medicine programs (RMAT & ATMP).
Dr. Milne became Director of Research at Tufts CSDD in 2011, and a Research Associate Professor at Tufts University Medical School in 2014. He served as a visiting fellow at the Innogen Center, University of Edinburgh, Scotland in the fall of 2006. More recently in the spring of 2015, Dr. Milne was a visiting professor at Kyushu University in Fukuoka, Japan.
Although Dr. Milne recently retired from Tufts University, he continues to serve as a Research Associate at the Innogen Center and remains on the editorial boards of Therapeutic Innovation & Regulatory Science (TIRS) and Pharma Focus Asia. Dr. Milne received a BA from Fordham University, an MPH from The Johns Hopkins University, and holds doctoral degrees in veterinary medicine and law, respectively from UNPHU and UNH, and is a licensed attorney in the state of New Hampshire.
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).